BioAesthetics

BioAesthetics was founded in 2015 as a Tulane University spin-out with the mission to improve reconstruction options for breast cancer patients after they undergo mastectomies. The BioAesthetics initial product is a tissue-engineered nipple-areolar complex (NAC). This product will be provided to plastic and reconstructive surgeons as an off-the-shelf ready, acellular, NAC graft. During the breast reconstruction phase, after a mastectomy, the surgeon would engraft the NAC graft in position onto the patients reconstructed breast. The patients body would then use this NAC graft as a building frame to regenerate their own NAC. This patent-pending product is currently in the pre-clinical...

Bioaesthetics operates in the Biotechnology research industry.

Bioaesthetics's revenue is 1m - 10m

Bioaesthetics has 11 - 50 employees.